Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Active Pharmaceutical Ingredients (API) Market

Veterinary Active Pharmaceutical Ingredients (API) Market Size

  • Report ID: GMI5410
  • Published Date: Jul 2023
  • Report Format: PDF

Veterinary Active Pharmaceutical Ingredients Market Size

Veterinary Active Pharmaceutical Ingredients Market size was valued to be USD 6.3 billion in 2022 and is projected to witness growth at a CAGR of 7% by 2032 due to the rising ownership of companion animals, increasing prevalence of animal diseases, rising livestock production, growing awareness of zoonotic diseases, increasing demand for pet insurance, and expansion of companion animal drugs industry.

 

Veterinary API (Active Pharmaceutical Ingredient) refers to the active chemical component in a pharmaceutical product specifically designed for use in veterinary medicine. These APIs are responsible for the therapeutic or pharmacological effects of the veterinary drugs as they serve as the core ingredient in various pharmaceutical formulations. Veterinary APIs are subject to rigorous quality and safety standards to ensure they are effective and safe for use in animals. They undergo extensive research, development, and testing before they are approved for commercial use. The veterinary pharmaceutical industry continuously works to develop and improve APIs to provide better treatment options and promote animal health and welfare.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for veterinary active pharmaceutical ingredients valued to be USD 6.3 billion in 2022 and is projected to witness growth at a CAGR of 7% through 2032 due to increasing prevalence of animal diseases.

Chemical-based API segment held a major market share of 57.4% in 2022 and is expected to record healthy growth as these chemical based APIs have pharmacological activity mainly used with combination of other ingredients to diagnose, cure, mitigate, and treat veterinary diseases.

North America region held more than 39% revenue share in 2022 and is expected to reach over USD 4.5 billion by 2032, attributed to the significant pet expenditure, presence of large number of grazing animals, and supportive government initiatives.

Vetpharma, Huvepharma, Alivira Animal Health Ltd, NGL Fine-Chem Ltd, Excel Industries Ltd., INDUKERN Chemie AG, and AMGIS Lifescience Ltd. among others.

Veterinary Active Pharmaceutical Ingredients Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 257
  • Countries covered: 23
  • Pages: 236
 Download Free Sample